Abstract:Recently, the gut‐brain axis has received a lot of attention as some probiotics have been reported to have a beneficial effect on CNS diseases. Our previous studies show that the probiotic strain, Bifidobacterium breve MCC1274 (synonym B. breve A1), improves memory scores in Alzheimer’s disease model and human subjects with self‐reported memory complaints. Furthermore, in a trial with healthy adults with MCI (Mild Cognitive Impairment), we found that B. breve MCC1274 significantly improved the cognitive function [1]. In the present study, we investigated the association of blood parameters with the improvement of cognitive function by B. breve MCC1274. In a double blind, randomized placebo‐controlled trial, healthy adults aged 50‐79 years with MCI consumed probiotic capsules (2x1010 CFU/day) or placebo capsules for 16 weeks. Cognitive function was measured before and after the intervention using RBANS (Repeatable Battery for the Assessment of Neuropsychological Status) and JMCIS (Japanese version of MCI Screen) as neuropsychological tests. Hematological and biological blood parameters were measured to assess the safety and elucidate the possible action mechanism. Out of 80 participants, 79 subjects completed the study and after 16 weeks intervention, RBANS total score was significantly improved in the probiotic group in particular with significant improvement in domain scores of immediate memory, visuospatial/constructional, and delayed memory. Hematological and biological blood parameters showed no significant differences between the two groups. Interestingly, however, a significant correlation was found between the changes in blood HbA1c and RBANS total score in B. breve MCC1274 group (ρ=‐0.4218, p=0.0067). A stratified analysis based on baseline HbA1c with a median value (5.4%) showed a more remarkable benefit on the cognitive function by the probiotic consumption in the higher median subgroup (Fig 1). As many studies have reported an association between HbA1c and inflammation‐related dementia, this data suggests the mechanism of action of the probiotics may involve reducing inflammation. The present data shows that B. breve MCC1274 improves cognitive function by reducing inflammation in healthy adults with MCI and may be a potential strategy for preventing dementia. Reference: (1) Xiao et al. Journal of Alzheimer’s Disease, 2020.

Probiotic Supplementation Improves Cognitive Function and Mood with Changes in Gut Microbiota in Community-Dwelling Older Adults: A Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial

Cognitive and Emotional Effect of a Multi-species Probiotic Containing Lactobacillus rhamnosus and Bifidobacterium lactis in Healthy Older Adults: A Double‐Blind Randomized Placebo‐Controlled Crossover Trial

Probiotic Supplementation Demonstrates Therapeutic Potential in Treating Gut Dysbiosis and Improving Neurocognitive Function in Age-Related Dementia

The gut microbiome, mild cognitive impairment, and probiotics: A randomized clinical trial in middle-aged and older adults

Probiotic Intervention Benefits Multiple Neural Behaviors in Older Adults with Mild Cognitive Impairment

Effects of human probiotics on memory and psychological and physical measures in community-dwelling older adults with normal and mildly impaired cognition: results of a bi-center, double-blind, randomized, and placebo-controlled clinical trial (CleverAge biota)

Efficacy of probiotics on cognition, and biomarkers of inflammation and oxidative stress in adults with Alzheimer’s disease or mild cognitive impairment — a meta-analysis of randomized controlled trials

Evaluation of improvement of cognitive impairment in older adults with probiotic supplementation: A systematic review and meta-analysis

Anti‐inflammation as one of the mechanisms in the improvement of cognitive function by probiotic Bifidobacterium breve strain

Probiotic supplementation improved cognitive function in cognitively impaired and healthy older adults: a systematic review of recent trials

Probiotics Improve Cognitive Impairment by Decreasing Bacteria-Related Pattern Recognition Receptor-Mediated Inflammation in the Gut-Brain Axis of Mice

Probiotic Lactobacillus fermentum strain JDFM216 improves cognitive behavior and modulates immune response with gut microbiota

Evaluation of a probiotic blend on psychosocial health and biomarkers of inflammatory, immune and stress response in adults with subthreshold depression: a double-blind, randomised, placebo-controlled trial

Probiotics-induced changes in gut microbial composition and its effects on cognitive performance after stress: exploratory analyses

Multi-Strain Probiotic Mixture Affects Brain Morphology and Resting State Brain Function in Healthy Subjects: An RCT

Lactobacillus gasseri KS-13, Bifidobacterium bifidum G9-1, and Bifidobacterium longum MM-2 Ingestion Induces a Less Inflammatory Cytokine Profile and a Potentially Beneficial Shift in Gut Microbiota in Older Adults: A Randomized, Double-Blind, Placebo-Controlled, Crossover Study

Effects of Probiotics on Cognitive Reactivity, Mood, and Sleep Quality

The effects of probiotic supplements on oxidative stress and inflammation in subjects with mild and moderate Alzheimer's disease: a randomized, double-blind, placebo-controlled study

Probiotics treatment improves cognitive impairment in patients and animals: A systematic review and meta-analysis

Impact of probiotics on cognition and constipation in the elderly: A meta-analysis